Colon Cancer Cells Evade Drug Action by Enhancing Drug Metabolism
B. Cong, T. Thakur, A. H. Uribe…·R. Cagan
The paper identifies glucuronidation pathway upregulation as a mechanism by which colon cancer cells develop resistance to trametinib, showing that inhibiting this pathway can reverse resistance in both Drosophila and mouse models.